IP Verse

Biomarin Pharmaceutical Inc. opposition analysis

COMPANY ANALYSIS

Latest patents of Biomarin Pharmaceutical Inc. opposed by its competitors

Patent:
EP3461503
Grant Date:
May 11, 2022
Title:
Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring
Oppositions:
5
Patent:
EP3138566
Grant Date:
Jan 26, 2022
Title:
Treatment Of Phenylketonuria With Bh4
Oppositions:
3
Patent:
EP3175863
Grant Date:
Dec 1, 2021
Title:
Variants Of C-Type Natriuretic Peptide
Oppositions:
1
Patent:
EP2545939
Grant Date:
Dec 16, 2020
Title:
Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring
Oppositions:
5

Competitors of Biomarin Pharmaceutical Inc.

DIPHARMA S.A.

STADA ARZNEIMITTEL AG

BETAPHARM ARZNEIMITTEL GMBH

Want to track Biomarin Pharmaceutical Inc.?

Feel free to send us a message here and we will get back to you